Medications to ease intrauterine device insertion: a systematic review

Contraception

Volumn 94, Issue 6, 2016, Pages 739-759

  Zapata, Lauren B ^a   Jatlaoui, Tara C ^a   Marchbanks, Polly A ^a   Curtis, Kathryn M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Insertion difficulty; Intrauterine devices; Lidocaine; Misoprostol; Nitric oxide donors; Systematic review

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; DICLOFENAC; GLYCERYL TRINITRATE; LEVONORGESTREL; LIDOCAINE; MISOPROSTOL; NITROPRUSSIDE SODIUM; PLACEBO;

COPPER INTRAUTERINE DEVICE; DRUG EFFICACY; GEL; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; LEVONORGESTREL RELEASING INTRAUTERINE SYSTEM; OUTCOME ASSESSMENT; PARACERVICAL BLOCK; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TOPICAL TREATMENT; VAGINAL DELIVERY; DEVICE SAFETY; FEMALE; PAIN;

EQUIPMENT SAFETY; FEMALE; HUMANS; INTRAUTERINE DEVICES; MISOPROSTOL; NITROGLYCERIN; NITROPRUSSIDE; PAIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84995975840     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2016.06.014     Document Type: Review

References (55)

1. [1] Trussell, J, Contraceptive failure in the United States. Contraception 83 (2011), 397–404.
2. [2] Centers for Disease Control and Prevention, U.S. Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR Recomm Rep 59 (2010), 1–86.
3. [3] Branum, AM, Jones, J, Trends in long-acting reversible contraception use among U.S. women aged 15–44. NCHS Data Brief, 2015, 1–8.
4. [4] Daniels, K, Daugherty, J, Jones, J, Mosher, W, Current contraceptive use and variation by selected characteristics among women aged 15–44: United States, 2011–2013. Natl Health Stat Rep, 2015, 1–14.
5. [5] Romero, L, Pazol, K, Warner, L, et al. Vital signs: trends in use of long-acting reversible contraception among teens aged 15–19 years seeking contraceptive services — United States, 2005–2013. MMWR Morb Mortal Wkly Rep 64 (2015), 363–369.
6. [6] Gomez, AM, Hartofelis, EC, Finlayson, S, Clark, JB, Do knowledge and attitudes regarding intrauterine devices predict interest in their use?. Womens Health Issues 25 (2015), 359–365.
7. [7] Hubacher, D, Spector, H, Monteith, C, Chen, PL, Hart, C, Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception. Contraception 91 (2015), 185–192.
8. [8] Potter, J, Rubin, SE, Sherman, P, Fear of intrauterine contraception among adolescents in New York City. Contraception 89 (2014), 446–450.
9. [9] Buhling, KJ, Hauck, B, Dermout, S, Ardaens, K, Marions, L, Understanding the barriers and myths limiting the use of intrauterine contraception in nulliparous women: results of a survey of European/Canadian healthcare providers. Eur J Obstet Gynecol Reprod Biol 183 (2014), 146–154.
10. [10] Teal, SB, Romer, SE, Goldthwaite, LM, Peters, MG, Kaplan, DW, Sheeder, J, Insertion characteristics of intrauterine devices in adolescents and young women: success, ancillary measures, and complications. Am J Obstet Gynecol 213 (2015), 515.e1–515.e5.
11. [11] Bahamondes, MV, Hidalgo, MM, Bahamondes, L, Monteiro, I, Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Contraception 84 (2011), e11–e16.
12. [12] Brown, WM, Trouton, K, Intrauterine device insertions: which variables matter?. J Fam Plann Reprod Health Care 40 (2014), 117–121.
13. [13] Hubacher, D, Reyes, V, Lillo, S, Zepeda, A, Chen, PL, Croxatto, H, Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol 195 (2006), 1272–1277.
14. [14] Maguire, K, Davis, A, Rosario Tejeda, L, Westhoff, C, Intracervical lidocaine gel for intrauterine device insertion: a randomized controlled trial. Contraception 86 (2012), 214–219.
15. [15] Lopez, LM, Bernholc, A, Zeng, Y, et al. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev, 7, 2015, CD007373.
16. [16] Gemzell-Danielsson, K, Mansour, D, Fiala, C, Kaunitz, AM, Bahamondes, L, Management of pain associated with the insertion of intrauterine contraceptives. Hum Reprod Update 19 (2013), 419–427.
17. [17] Grimes, DA, Hubacher, D, Lopez, LM, Schulz, KF, Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine device use. Cochrane Database Syst Rev, 2006, Cd006034.
18. [18] Pergialiotis, V, Vlachos, DG, Protopappas, A, Vlachos, GD, Analgesic options for placement of an intrauterine contraceptive: a meta-analysis. Eur J Contracept Reprod Health Care 19 (2014), 149–160.
19. [19] Dehlendorf, C, Tharayil, M, Anderson, N, Gbenedio, K, Wittman, A, Steinauer, J, Counseling about IUDs: a mixed-methods analysis. Perspect Sex Reprod Health 46 (2014), 133–140.
20. [20] Centers for Diseaes Control and Prevention, U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization Selected Practice Recommendations for Contraceptive Use., 2nd ed. MMWR recommendations and reports: morbidity and mortality weekly report recommendations and reports/centers for disease control, 62, 2013, 1–60.
21. [21] Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ, 339, 2009, b2535.
22. [22] Harris, RP, Helfand, M, Woolf, SH, et al. Current methods of the US preventive services task force: a review of the process. Am J Prev Med 20 (2001), 21–35.
23. [23] Bahamondes, MV, Espejo-Arce, X, Bahamondes, L, Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCT. Hum Reprod, 2015.
24. [24] Dijkhuizen, K, Dekkers, OM, Holleboom, CA, et al. Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. Hum Reprod 26 (2011), 323–329.
25. [25] Edelman, AB, Schaefer, E, Olson, A, et al. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception 84 (2011), 234–239.
26. [26] Espey, E, Singh, RH, Leeman, L, Ogburn, T, Fowler, K, Greene, H, Misoprostol for intrauterine device insertion in nulliparous women: a randomized controlled trial. Am J Obstet Gynecol 210 (2014), 208.e1–208.e5.
27. [27] Heikinheimo, O, Inki, P, Kunz, M, et al. Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception 81 (2010), 481–486.
28. [28] Ibrahim, ZM, Sayed Ahmed, WA, Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery. Eur J Contracept Reprod Health Care 18 (2013), 300–308.
29. [29] Lathrop, E, Haddad, L, McWhorter, CP, Goedken, P, Self-administration of misoprostol prior to intrauterine device insertion among nulliparous women: a randomized controlled trial. Contraception 88 (2013), 725–729.
30. [30] Lotke, PS, Tiwari, A, Leybas, NV, Inserting intrauterine devices in nulliparous women: is misoprostol beneficial? A registered clinical trial. Am J Clin Exp Obstet Gynecol 1 (2013), 62–68.
31. [31] Scavuzzi, A, Souza, AS, Costa, AA, Amorim, MM, Misoprostol prior to inserting an intrauterine device in nulligravidas: a randomized clinical trial. Hum Reprod 28 (2013), 2118–2125.
32. [32] Swenson, C, Turok, DK, Ward, K, Jacobson, JC, Dermish, A, Self-administered misoprostol or placebo before intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstet Gynecol 120 (2012), 341–347.
33. [33] Allen, RH, Raker, C, Goyal, V, Higher dose cervical 2% lidocaine gel for IUD insertion: a randomized controlled trial. Contraception 88 (2013), 730–736.
34. [34] Bednarek, PH, Micks, EA, Edelman, AB, Li, H, Jensen, JT, The effect of nitroprusside on IUD insertion experience in nulliparous women: a pilot study. Contraception 87 (2013), 421–425.
35. [35] Castro, TV, Franceschini, SA, Poli-Neto, O, Ferriani, RA, Silva de Sa, MF, Vieira, CS, Effect of intracervical anesthesia on pain associated with the insertion of the levonorgestrel-releasing intrauterine system in women without previous vaginal delivery: a RCT. Hum Reprod 29 (2014), 2439–2445.
36. [36] Micks, EA, Jensen, JT, Bednarek, PH, The effect of nitroglycerin on the IUD insertion experience in nulliparous women: a pilot study. Contraception 90 (2014), 60–65.
37. [37] Fouda, UM, Salah Eldin, NM, Elsetohy, KA, Tolba, HA, Shaban, MM, Sobh, SM, Diclofenac plus lidocaine gel for pain relief during intrauterine device insertion. A randomized, double-blinded, placebo-controlled study. Contraception 93 (2016), 513–518.
38. [38] Shahnazi, M, Nikjoo, R, Yavarikia, P, Mohammad-Alizadeh-Charandabi, S, Inhaled lavender effect on anxiety and pain caused from intrauterine device insertion. J Caring Sci 1 (2012), 255–261.
39. [39] Cameron, ST, Glasier, A, Cooper, A, Johnstone, A, Does a full bladder assist insertion of intrauterine contraception? A randomised trial. J Fam Plann Reprod Health Care 39 (2013), 207–210.
40. [40] Karabayirli, S, Ayrim, AA, Muslu, B, Comparison of the analgesic effects of oral tramadol and naproxen sodium on pain relief during IUD insertion. J Minim Invasive Gynecol 19 (2012), 581–584.
41. [41] Massey, SE, Varady, JC, Henzl, MR, Pain relief with naproxen following insertion of an intrauterine device. J Reprod Med 13 (1974), 226–231.
42. [42] Saav, I, Aronsson, A, Marions, L, Stephansson, O, Gemzell-Danielsson, K, Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod 22 (2007), 2647–2652.
43. [43] Jensen, HH, Blaabjerg, J, Lyndrup, J, Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion. Ugeskr Laeger 160 (1998), 6958–6961.
44. [44] Aksoy, H, Aksoy, U, Ozyurt, S, Acmaz, G, Babayigit, M, Lidocaine 10% spray to the cervix reduces pain during intrauterine device insertion: a double-blind randomised controlled trial. J Fam Plann Reprod Health Care, 2015.
45. [45] Bednarek, PH, Creinin, MD, Reeves, MF, Cwiak, C, Espey, E, Jensen, JT, Prophylactic ibuprofen does not improve pain with IUD insertion: a randomized trial. Contraception 91 (2015), 193–197.
46. [46] Chor, J, Bregand-White, J, Golobof, A, Harwood, B, Cowett, A, Ibuprofen prophylaxis for levonorgestrel-releasing intrauterine system insertion: a randomized controlled trial. Contraception 85 (2012), 558–562.
47. [47] Cirik, D, Taşkın, EA, Tuğlu, A, Ortac, A, Dai, O, Paracervical block with 1% lidocaine for pain control during intrauterine device insertion: a prospective, single-blinded, controlled study. Int J Reprod Contracept Obstet Gynecol 2 (2013), 263–267.
48. [48] McNicholas, CP, Madden, T, Zhao, Q, Secura, G, Allsworth, JE, Peipert, JF, Cervical lidocaine for IUD insertional pain: a randomized controlled trial. Am J Obstet Gynecol 207 (2012), 384.e1–384.e6.
49. [49] Mody, SK, Kiley, J, Rademaker, A, Gawron, L, Stika, C, Hammond, C, Pain control for intrauterine device insertion: a randomized trial of 1% lidocaine paracervical block. Contraception 86 (2012), 704–709.
50. [50] Mohammad-Alizadeh-Charandabi, S, Seidi, S, Kazemi, F, Effect of lidocaine gel on pain from copper IUD insertion: a randomized double-blind controlled trial. Indian J Med Sci 64 (2010), 349–355.
51. [51] Nelson, AL, Fong, JK, Intrauterine infusion of lidocaine does not reduce pain scores during IUD insertion. Contraception 88 (2013), 37–40.
52. [52] Ngo, LL, Ward, KK, Mody, SK, Ketorolac for pain control with intrauterine device placement. Obstet Gynecol 126 (2015), 29–36.
53. [53] Tavakolian, S, Ghorbani, M, Doulabi, MA, Baghban, AA, Mortazavi, A, Lidocaine-Prilocaine cream as analgesia for IUD insertion: a prospective, randomized, controlled, triple blinded study. Glob J Health Sci 7 (2015), 399–404.
54. [54] Tornblom-Paulander, S, Tingaker, BK, Werner, A, et al. Novel topical formulation of lidocaine provides significant pain relief for intrauterine device insertion: pharmacokinetic evaluation and randomized placebo-controlled trial. Fertil Steril 103 (2015), 422–427.
55. [55] Li, YT, Kuo, TC, Kuan, LC, Chu, YC, Cervical softening with vaginal misoprostol before intrauterine device insertion. Int J Gynaecol Obstet 89 (2005), 67–68.